Zepp Health (ZEPP) Price to Sales (2018 - 2026)

Zepp Health has reported Price to Sales for 9 years, with the latest figure at 1.39 in Q2 2026.

• On a quarterly basis, Price to Sales rose 89.51% year-over-year to 1.39 in Q2 2026; TTM through Jun 2026 was 0.32, a 46.8% increase from a year earlier, with the FY2025 full-year figure at 1.76, up 656.14% from the prior year.
• Price to Sales was 1.39 for Q2 2026 at Zepp Health, down from 3.92 in the prior quarter.
• The five-year high for Price to Sales was 9.88 in Q3 2025, with the low at 0.51 in Q3 2022.
• Average Price to Sales over 5 years is 1.92, with a median of 1.04 recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Price to Sales sank 74.54% in 2022, then surged 649.52% in 2025.
• Over 5 years, Price to Sales stood at 0.6 in 2022, then jumped by 85.33% to 1.12 in 2023, then slumped by 36.03% to 0.71 in 2024, then soared by 649.52% to 5.35 in 2025, then plunged by 74.07% to 1.39 in 2026.
• The last three Price to Sales figures came in at 1.39 (Q2 2026), 3.92 (Q1 2026), and 5.35 (Q4 2025), per Business Quant data.